Drug Trial Radar · NCT02479347
Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine
Last checked: Nov 19, 2026Latest source record: Sep 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,158
Actual
Start
Mar 2013
Primary completion
Sep 2016
Study completion Sep 2016
Sponsor
- Lead sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 24, 2015
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The development of surgical site infections (SSI) in clean-contaminated surgery is regarded as being preventable. Known to be effective in the prevention of surgical site infection are the adequate sterilization of the surgical instruments, asepsis during operation, antibiotic prophylaxis where indicated, and certainly the preparation of the skin at the incision site, since the patient's skin is the principal source of bacterial contamination of the wound. This study aims to investigate the efficacy in prevention of surgical site infection in clean surgery, using two different standardized methods of skin preparation: povidone-iodine 10% aqueous solution from 1.5 liter bulk bottle, versus tinted 2% chlorhexidine in 70% isopropyl alcohol in a single-dose applicator. To reduce the variables involved, a single-center study will enroll a homogeneous population, undergoing breast cancer surgery.
Conditions
- Wound Infection
- Breast Neoplasms
Interventions
ChlorhexidineDrug
Preoperative skin preparation with tinted chlorhexidine gluconate 2% in 70% isopropyl alcohol administered with single-dose applicator
Povidone-IodineDrug
Preoperative skin preparation with povidone-iodine 10% aqueous solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of wound infection after surgery (composite outcome)Time frame: 30 days after surgery without breast implant and 180 days after surgery with implant
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Mi, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.